NPCE insider transaction filings
NeuroPace Inc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-21. Screen NPCE transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Becker Joel — CHIEF EXECUTIVE OFFICER, Director | 2 | — | — | 2 |
| Morrell Martha — CHIEF MEDICAL OFFICER | 2 | — | — | 2 |
| Williams Patrick F. — Chief Financial Officer | 1 | — | — | 1 |
Recent Form 4 filings — NeuroPace Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Williams Patrick F. — Chief Financial Officer | Tax withholding (F): 1,162 @ $14.28 | EDGAR |
| 2026-09-04 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,310 @ $14.75 | EDGAR |
| 2026-08-28 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 358 @ $14.13 | EDGAR |
| 2026-08-28 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,126 @ $14.13 | EDGAR |
| 2026-06-25 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 335 @ $16.22 | EDGAR |
| 2026-06-22 | 4 | Kumar Rakhi — Director | Grant/award (A): 989 @ $15.63 | EDGAR |
| 2026-06-22 | 4 | Geiger Uri — Director | Grant/award (A): 789 @ $15.63 | EDGAR |
| 2026-06-22 | 4 | Fischer Frank M — Director | Grant/award (A): 1,467 @ $15.63 | EDGAR |
| 2026-06-05 | 4 | Kumar Rakhi — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Ryan Renee — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Andrade Lisa — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Geiger Uri — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Huennekens R Scott — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Fischer Frank M — Director | Grant/award (A): 2,890 @ $0 · Grant/award (A): 5,368 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,255 @ $15.88 | EDGAR |
| 2026-05-28 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 358 @ $17.06 | EDGAR |
| 2026-05-28 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,126 @ $17.06 | EDGAR |
| 2026-05-19 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Grant/award (A): 5,460 @ $0 · Grant/award (A): 14,550 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Williams Patrick F. — Chief Financial Officer | Grant/award (A): 16,820 @ $0 · Grant/award (A): 44,800 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 45,880 @ $0 · Grant/award (A): 122,190 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 1,341 @ $13.27 | EDGAR |
| 2026-03-24 | 4 | Geiger Uri — Director | Grant/award (A): 913 @ $13 | EDGAR |
| 2026-03-24 | 4 | LACOB JOSEPH — Director | Grant/award (A): 865 @ $13 | EDGAR |
| 2026-03-23 | 4 | Kumar Rakhi — Director | Grant/award (A): 1,153 @ $13 | EDGAR |
| 2026-03-23 | 4 | Fischer Frank M — Director | Grant/award (A): 1,826 @ $13 | EDGAR |
| 2026-03-04 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Sale (S): 25,000 @ $15.97 · Tax withholding (F): 1,340 @ $13.83 | EDGAR |
| 2026-03-04 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 5,023 @ $13.83 | EDGAR |
| 2026-03-02 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 358 @ $14.58 | EDGAR |
| 2026-03-02 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,126 @ $14.58 | EDGAR |
| 2026-02-23 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 3,412 @ $14.34 | EDGAR |
| 2025-12-23 | 4 | Kumar Rakhi — Director | Grant/award (A): 904 @ $16.59 | EDGAR |
| 2025-12-23 | 4 | Geiger Uri — Director | Grant/award (A): 715 @ $16.59 | EDGAR |
| 2025-12-23 | 4 | Fischer Frank M — Director | Grant/award (A): 1,431 @ $16.59 | EDGAR |
| 2025-12-23 | 4 | LACOB JOSEPH — Director | Grant/award (A): 678 @ $16.59 | EDGAR |
| 2025-12-04 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 1,338 @ $16.66 | EDGAR |
| 2025-12-01 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 357 @ $16.50 | EDGAR |
| 2025-12-01 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,126 @ $16.50 | EDGAR |
| 2025-11-24 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 3,051 @ $13.50 | EDGAR |
| 2025-09-22 | 4 | Kumar Rakhi — Director | Grant/award (A): 1,509 @ $9.94 | EDGAR |
| 2025-09-22 | 4 | Geiger Uri — Director | Grant/award (A): 1,194 @ $9.94 | EDGAR |
| 2025-09-22 | 4 | Fischer Frank M — Director | Grant/award (A): 2,389 @ $9.94 | EDGAR |
| 2025-09-22 | 4 | LACOB JOSEPH — Director | Grant/award (A): 1,131 @ $9.94 | EDGAR |
| 2025-09-04 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 1,337 @ $9.36 | EDGAR |
| 2025-08-28 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 357 @ $8.88 | EDGAR |
| 2025-08-28 | 4 | Becker Joel — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 1,126 @ $8.88 | EDGAR |
| 2025-08-22 | 4 | Morrell Martha — CHIEF MEDICAL OFFICER | Tax withholding (F): 3,052 @ $8.66 | EDGAR |
| 2025-06-24 | 4 | Kumar Rakhi — Director | Grant/award (A): 3,340 @ $4.49 · Grant/award (A): 1,541 @ $9.73 · Grant/award (A): 1,454 @ $10.31 · Grant/award (A): 1,136 @ $13.20 · Grant/award (A): 1,984 @ $7.56 · Grant/award (A): 2,152 @ $6.97 · +3 more | EDGAR |
| 2025-06-24 | 4 | Geiger Uri — Director | Grant/award (A): 2,337 @ $4.49 · Grant/award (A): 1,220 @ $9.73 · Grant/award (A): 1,151 @ $10.31 · Grant/award (A): 899 @ $13.20 · Grant/award (A): 1,570 @ $7.56 · Grant/award (A): 1,703 @ $6.97 · +3 more | EDGAR |
| 2025-06-24 | 4 | Fischer Frank M — Director | Grant/award (A): 4,469 @ $4.49 · Grant/award (A): 2,440 @ $9.73 · Grant/award (A): 2,303 @ $10.31 · Grant/award (A): 1,799 @ $13.20 · Grant/award (A): 3,141 @ $7.56 · Grant/award (A): 3,407 @ $6.97 · +3 more | EDGAR |
| 2025-06-24 | 4 | LACOB JOSEPH — Director | Grant/award (A): 2,505 @ $4.49 · Grant/award (A): 1,156 @ $9.73 · Grant/award (A): 1,091 @ $10.31 · Grant/award (A): 852 @ $13.20 · Grant/award (A): 1,488 @ $7.56 · Grant/award (A): 1,614 @ $6.97 · +3 more | EDGAR |
Recent 8-K events — NeuroPace Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NPCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →